This is similar to the vulnerability factor EphA4, the suppression of which has been shown to be beneficial across ALS-causative SOD1 and TDP-43 mutations, as well as in SMN loss, with the main function being axon regeneration [68]. The gene discussed is SMN2; the disease is amyotrophic lateral sclerosis.